Related Experiment Video
Updated: Jun 5, 2026

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
Published on: April 18, 2011
Spasticity mechanisms - for the clinician
Angshuman Mukherjee1, Ambar Chakravarty
1Department of Neurology, Vivekananda Institute of Medical Sciences Kolkata, India.
Spasticity, a symptom of upper motor neuron lesions, involves increased muscle tone due to heightened stretch reflex excitability. This condition results from complex central nervous system adaptations following brain or spinal cord injuries.
Area of Science:
- Neuroscience
- Clinical Neurology
- Physiology
Background:
- Spasticity is a hallmark of upper motor neuron lesions, characterized by velocity-dependent increases in muscle tone.
- Clinically, it presents as resistance to passive stretching, often accompanied by phenomena like clonus and spasms.
- The underlying mechanism involves increased muscle stretch reflex excitability, linked to muscle spindle activity and spinal circuitry influenced by supraspinal pathways.
Purpose of the Study:
- To elucidate the complex mechanisms contributing to human spasticity.
- To understand the role of spinal and supraspinal pathways in the development of spasticity.
- To explore the neuroplastic changes underlying spasticity following central nervous system lesions.
Main Methods:
- Review of traditional and physiological definitions of spasticity.
- Analysis of clinical manifestations and associated phenomena.
- Investigation of the role of muscle spindles, spinal circuits, and supraspinal control.
- Consideration of central nervous system adaptations and neuroplasticity.
Main Results:
- Spasticity arises from increased muscle stretch reflex excitability, influenced by supraspinal pathways.
- Adaptations in spinal neuronal circuitry, including reduced inhibitory mechanisms, are implicated.
- Delayed onset and eventual reduction in reflex excitability suggest plastic changes in the central nervous system.
- Multiple, not fully elucidated, mechanisms likely contribute to human spasticity.
Conclusions:
- Human spasticity results from a complex interplay of factors, including altered supraspinal control and spinal adaptations.
- Neuroplastic changes in the central nervous system play a significant role in the development and progression of spasticity.
- Further research is needed to fully understand the mechanisms of spasticity and guide the development of effective treatments.
Related Concept Videos
Alterations in Muscle Tone ll
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
Alterations in Muscle Tone lll
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Skeletal Muscle Relaxants: Therapeutic Uses
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
